Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

8,017 public trials 743 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.

NCT05158387

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Research Site Sheffield, Alabama, United States
  • Research Site Lincoln, California, United States
  • Research Site Newport Beach, California, United States
  • Research Site Northridge, California, United States
View all 212 locations
View Trial Details
Completed

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

NCT05166889

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Mobile, Alabama, United States
  • Research Site Montgomery, Alabama, United States
  • Research Site Phoenix, Arizona, United States
View all 212 locations
View Trial Details
Completed

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

NCT04701983

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • University of Alabama at Birmingham Site Number : 8400012 Birmingham, Alabama, United States
  • Jasper Summit Research Site Number : 8400178 Jasper, Alabama, United States
  • Chandler Clinical Trials (Elite Clinical Network) Site Number : 8400034 Chandler, Arizona, United States
  • Pulmonary Associates Site Number : 8400392 Phoenix, Arizona, United States
View all 248 locations
View Trial Details
Completed

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

NCT04751487

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Synexus Phoenix Central (Central Phoenix Medical Clinic)- Site Number : 8400333 Phoenix, Arizona, United States
  • UCSF Fresno - Site Number : 8400030 Fresno, California, United States
  • Palmtree Clinical Research Site Number : 8400184 Palm Springs, California, United States
  • Allianz Research Institute Colorado Site Number : 8400061 Denver, Colorado, United States
View all 297 locations
View Trial Details

Related conditions